The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASE I F COD FOLL SEQ IMAGE EVENT DT MFR DT FDA DT REPT COD MFR NUM MFR SNDR AGE AGE COD GNDR COD E SUB WT WT COD REPT DT OCCP COD DEATH DT TO MFR CONFID REPORTER COUNTRY
8016622 8317512 I 8016622-5 20111221 20111231 EXP CHPA2011CA018482 NOVARTIS CONSUMER HEALTH, INC. YR F Y 20111231 CN CANADA

Drug(s) used by person

Event ID DRUG SEQ ROLE COD DRUGNAME VAL VBM ROUTE DOSE VBM DECHAL RECHAL LOT NUM EXP DT NDA NUM
8016622 1018419896 PS NEOCITRAN EXTRA STRENGTH COLDS AND FLU 2 ORAL 1 DF, QHS

Indications of drugs used

Event ID DRUG SEQ INDI PT
8016622 1018419896 NASOPHARYNGITIS

Outcome of event

Event ID OUTC COD
8016622 OT

Reactions reported

Event ID PT
8016622 COELIAC DISEASE
8016622 MATERNAL EXPOSURE DURING PREGNANCY

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found